Initiative dedicated to providing kidney patients information to all available care options

 NASHVILLE, Tenn. (November 2, 2021) — Monogram Health, a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease, announced today it is joining Innovate Kidney Care (IKC), an educational campaign advocating for people with kidney diseases to improve patient options for home dialysis training and support. Effective immediately, Monogram Health will become an IKC supporting member.

 37 million Americans are affected by kidney disease and 550,000 annually are on dialysis.  However, the pathway to choosing where and how to do dialysis can sometimes be difficult for patients and their loved ones. Not all patients have access to the same choices for their dialysis care. Self-dialysis, including peritoneal dialysis and home hemodialysis, is a safe and effective treatment option for patients facing permanent kidney failure—also known as End-Stage Renal Disease (ESRD) or End-Stage Kidney Disease (ESKD)—while they wait for a kidney transplant, or if they’re ineligible for a transplant.

 Home dialysis offers logistical, economic, and quality of life benefits for patients experiencing kidney failure. However, despite these advantages, it is widely underutilized in the United States broadly and especially by lower-income, Black and Hispanic individuals. Through the IKC campaign, patients are becoming more aware of available options.

 “Monogram Health is committed to bringing the benefits of home-based care to patients living with kidney disease,” said Mike Uchrin, CEO of Monogram Health. “Through this important campaign, we join other industry leaders in helping educate patients, families, health care providers, and policymakers on the disease and the full range of evidence-based treatment options, including home dialysis, kidney transplant, and conservative care.”

 Monogram Health is an innovative value-based provider focused exclusively on treating and managing chronic kidney disease (CKD) and end-stage renal disease (ESRD) at home. The company partners with health plans to provide their members with evidence-based nephrology, primary care, and benefit management services, including complex case and disease management, utilization management, and medication therapy management.  This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing costs for the health care system.

 Innovate Kidney Care’s diverse group of industry organizations aims to advocate for the Centers for Medicare & Medicaid Services (CMS) to modernize the ESRD Conditions for Coverage and related guidance in order to achieve the quadruple aim of better patient outcomes, improved patient experience, improved health care practitioner experience and lower costs of care.

 “Innovate Kidney Care is dedicated to accelerating patients’ access to home dialysis,” said Tonya Saffer, spokesperson for Innovate Kidney Care. “With Monogram Health adding its support, we can increase momentum and support for our efforts to modernize the Medicare End-Stage Renal Disease Conditions for Coverage and empower patient choice in the management of their care, regardless of race, ethnicity, or income.”

 Founding members of IKC include the American Society of Nephrology (ASN), Anthem, Inc., Cricket Health, CVS Kidney Care, Home Dialyzors United (HDU), Intermountain Healthcare, the National Kidney Foundation (NKF), Outset Medical, Inc. and Strive Health.

To learn more about Innovate Kidney Care, visit innovatekidneycare.com.

About Monogram Health 

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital,Monogram Health has numerous value-based partnerships with leading health plans to care for patients across 20 states and all insurance products. To learn more about Monogram Health, please visithere.

Contact information:
Kyle Cooksey
SVP, Marketing and Communications
Monogram Health
kyle.cooksey@monogramhealth.com
615.510.6492